Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study코로나바이러스 COVID19에 따른 간질성 폐렴 환자에서 바리시티닙과 토실리주맙 단독 요법 또는 병용 요법의 사용 경험: 실제 연구Article Published on 2022-03-012022-09-12 Journal: Reumatología clinica [Category] MERS, SARS, 진단, [키워드] Admission age average Baricitinib Combined COVID-19 COVID19 died discharge English experience group ICU interstitial pneumonia males media medical record monotherapy Neumonía intersticial PaO paO2/fiO2 Patient patients patients died Quince required secondary to Side effect Side effects Spanish Symptoms TCZ Tocilizumab treated Treatment UCI. [DOI] 10.1016/j.reumae.2020.10.006 PMC 바로가기 [Article Type] Article